Skip to main content
. 2022 Apr 14;12:864066. doi: 10.3389/fonc.2022.864066

Table 1.

Clinicopathological characteristics of the participants and their tumors.

Variable Frequency (%)
Age 38.0 (31.0 – 45.0) years
Sex

  • Male

 94/243 (38.7)

  • Female

 149/243 (61.3)
HIV status

  • Positive

 177/243 (72.8)

  • Negative

 66/243 (27.2)
Awareness HIV +

  • Aware HIV+

 163/177 (92.1)

  • Unaware HIV+

 14/177 (7.9)
ART Uptake

  • Yes

 151/177 (85.3)

  • No

 26/177 (14.7)
CD4 Count 234.0 (119.8 – 411.8) cells/microliter
CD4 Count category

  • <200

 70/160 (43.8)

  • >200

 90/160 (56.2)
Plasma HIV Viral load 0.0 (0.0 – 181.0) copies/milliliter
Plasma HIV Viral load (c)

  • <200

 71/95 (74.7)

  • >200

 24/95 (25.3)
Diagnosis

  • Invasive OSSN

 171 (70.4)

  • Pre-invasive OSSN

 72 (29.6)
Preinvasive tumor grade

  • CIN1

 2 (2.8)

  • CIN2

 8 (11.1)

  • CIN3

 25 (34.7)

  • CIS

 37 (51.4)
Grouped Preinvasive tumor grade

  • CIN1 and 2

 10 (13.9)

  • CIN3 and CIS

 62 (86.1)
Invasive tumor subtype

  • Keratinizing squamous cell carcinoma

 161 (94.2)

  • Basaloid squamous cell carcinoma

 6 (3.5)

  • Spindle squamous cell carcinoma

 4 (2.3)
Invasive tumor grouped

  • Keratinizing

 161 (94.2)

  • Non-keratinizing

 10 (5.8)
Grade

  • Well, differentiated

 21 (12.3)

  • Moderately differentiated

 140 (81.9)

  • Poorly differentiated

 10 (5.8)
AJCC Stage

  • T1

 38 (22.2)

  • T2

 42 (24.6)

  • T3

 88 (51.5)

  • T4

 3 (1.8)